Back to
Zürcher Kantonalbank
VKTX
Showing 8 of 28 quarters
Position history for
Zürcher Kantonalbank's holdings in Viking Therapeutics, Inc.
Yes. Zürcher Kantonalbank holds 50,273 shares of VKTX (Viking Therapeutics), worth $2M, as of its Q2 2026 13F filing. It increased the position by 3,487 shares (+7.5%) from Q1 2026. Zürcher Kantonalbank has held VKTX since Q1 2023, across 14 quarterly 13F filings.
Current Value
$2M
Current Shares
50,273
Total Value Change
+$516,226
Total Shares Change
+27,450
Quarter-by-Quarter History